BRIEFING. (EXC: K. Moore.) RTS C Propylparaben C 10 H 12 O Benzoic acid, 4 hydroxy, propyl ester; Propyl p hydroxybenzoate [ ].

Similar documents
BRIEFING. Pharmacopeial Discussion Group Sign Off Document Attributes EP JP USP Definition Loss on drying Readily carbonizable substances

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

NEVIRAPINE ORAL SUSPENSION Final text for addition to The International Pharmacopoeia (February 2009)

Revision Bulletin 27 Jan Feb 2017 Non-Botanical Dietary Supplements Compliance

Revision Bulletin 29 Dec Jan 2018 Non-Botanical Dietary Supplements Compliance

LUMEFANTRINUM LUMEFANTRINE

Dehydrated Alcohol. » Dehydrated Alcohol contains not less than 99.2 percent, Pharmacopeial Forum Vol. 30(5) [Sept. Oct. 2004] HARMONIZATION 1847

CYCLOSERINE Final text for addition to The International Pharmacopoeia. (November 2008) CYCLOSERINUM CYCLOSERINE

Additionally, minor editorial changes have been made to update the monograph to current USP style.

Should you have any questions, please contact Mary P. Koleck, Ph.D., Scientific Liaison ( or

ARTEMETHER AND LUMEFANTRINE TABLETS: Final text for addition to The International Pharmacopoeia (July 2008)

Dissolution Test 5 was validated using a Zodiac C18 brand of L1 column. The typical retention time for atorvastatin is about min.

BRIEFING. (EM2: K. Moore.) RTS C Add the following: Methylcellulose

ARTEMETHER AND LUMEFANTRINE ORAL SUSPENSION:Final text for addition to The International Pharmacopoeia (November 2008)

EFAVIRENZ Final text for addition to The International Pharmacopoeia

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

MEDROXYPROGESTERONE INJECTION

The Isosorbide Mononitrate Extended-Release Tablets Revision Bulletin supersedes the currently official monograph.

USP 36 Official Monographs / Metformin carding the first 3 ml of filtrate. Transfer 25 ml of the Analysis

ADVANTAME. Not less than 97.0% and not more than 102.0% on the anhydrous basis. Sweetener, flavour enhancer

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

Ondansetron Hydrochloride Tablets

Dissolution Test 2 was validated using an Inertsil ODS-3V brand of L1 column. The typical retention time for donepezil is about 5.5 min.

DOXYCYCLINE HYCLATE Final text to replace published monograph in The International Pharmacopoeia (November 2007)

Lonicera japonica Flower Dry Extract. Proposed For Development Version 0.1. Published on Herbal Medicines Compendium (

Revision Bulletin Official April 1, 2014 Alprazolam 1

Chapter 4: Verification of compendial methods

Lonicera japonica Flower Powder. Proposed For Development Version 0.1. Published on Herbal Medicines Compendium (

DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

IDENTIFICATION AND DETERMINATION OF HYDROQUINONE IN COSMETIC PRODUCTS 2 14/11/17 ACM 003 BY TLC AND HPLC

USP 35 Official Monographs / Oxaliplatin 4143 DEFINITION

This method describes the identification of the following prohibited colorants in cosmetic products:

What actually are dietary supplements? They are consumed in large quantities, but they

IDENTIFICATION OF STEROIDS IN COSMETIC PRODUCTS BY TLC AND HPLC 1 02/12/2005 ACM 007 A. THIN LAYER CHROMATOGRAPHY (TLC)

FLUDEOXYGLUCOSE ( 18 F) INJECTION: Final text for addition to The International Pharmacopoeia (January 2009)

ADVANTAME (TENTATIVE)

Change to read: PROCEDURE Buffer: 3.9 g/l of ammonium acetate in water. Adjust

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.

ANALYTICAL METHOD PROCEDURES

Chapter 5: Identification, Assay and Related Substances

TEMPLATE FOR AN EXAMPLE STANDARD TEST METHOD

ASPIRIN (ACETYLSALICYLIC ACID) CERTIFIED REFERENCE MATERIAL

Methyl Salicylate Technical Package

USP Method Transfer and Routine Use Analysis of Irbesartan Tablets from HPLC to UPLC

Int. J. Pharm. Sci. Rev. Res., 30(2), January February 2015; Article No. 09, Pages: 63-68

Development and Validation of a HPLC Method for Chlorphenamine Maleate Related Substances in Multicomponents Syrups and Tablets

GUACO FOR HOMOEOPATHIC PREPARATIONS GUACO FOR HOMOEOPATHIC PREPARATIONS

Fast methods for the determination of ibuprofen in drug products

Introduction to Pharmaceutical Chemical Analysis

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB5009.

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE

VALIDATION OF A UPLC METHOD FOR A BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE TOPICAL SOLUTION

Amendment to the Enforcement Ordinance of the Food Sanitation Law and the Standards and Specifications for Foods and Food Additives.

Mashhour Ghanem 1 and Saleh Abu-Lafi 2 * ABSTRACT ARTICLE INFO

Application Note. Pharmaceutical QA/QC. Author. Abstract. Siji Joseph Agilent Technologies, Inc. Bangalore, India

H 3 CO H 3 CO S CH 3

INDIGOTINE. Disodium 3,3'-dioxo-[delta 2,2' -biindoline]-5,5'-disulfonate (principal component) (principal component)

OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT

Method Development and Validation Of Prasugrel Tablets By RP- HPLC

METHOD DEVELOPMENT AND VALIDATION OF RALTEGRAVIR POTASSIUM AND RILPIVIRINE HCL BY HPLC AND HPTLC METHODS

Certificate of Analysis

Egualen Sodium Granules

High Performance Liquid Chromatography. Table 1: Allowed HPLC Adjustment of USP <621> and EP <2.2.46>

Journal of Drug Delivery and Therapeutics

12 Nicarbazin Nicarbazin (4,4 -dinitro carbanilid (DNC) and 2-hydroxy-4,6-dimethyl pyrimidine (HDP))

Ester Synthesis And Analysis: Aspirin and Oil of Wintergreen. Vanessa Jones November 19, 2015 Thursday 8:30 Lab Section Lab Partner: Melissa Blanco

USP 35 Official Monographs / Azithromycin 2279 C 38H 72N 2O 12 H 2O

ASPARTAME. Not less than 98% and not more than 102% on the dried basis. White, odourless, crystalline powder, having a strong sweet taste

DEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR IN-VIVO STUDY OF DICLOFENAC POTASSIUM

POLYVINYL ALCOHOL. SYNONYMS Vinyl alcohol polymer, PVOH, INS No DEFINITION DESCRIPTION FUNCTIONAL USES CHARACTERISTICS

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. NY/T Translated English of Chinese Standard: NY/T

Determination of Carbonyl Compounds In Water by Dinitrophenylhydrazine Derivatization and HPLC/UV*

Appendix II- Bioanalytical Method Development and Validation

SPECIFIC MONOGRAPH TECHNETIUM ( 99M TC) SUCCIMER INJECTION

PYRIPROXYFEN TECHNICAL

Impact factor: 3.958/ICV: 4.10 ISSN:

Certificate of Analysis

Cation Exchange HPLC Columns

Application Note Pharmaceutical QA/QC. Agilent Application Solution. Authors. Abstract. Syed Salman Lateef Agilent Technologies, Inc.

SPECIFICATION & TEST PROCEDURE SODIUM SALICYLATE Technical. Molecular weight : Reference : In-house

PHENYLEPHRINE HYDROCHLORIDE CERTIFIED REFERENCE MATERIAL

PDG.pdf G-20 CHROMATOGRAPHY 3 4 INTRODUCTION

Reverse Phase High Performance Liquid Chromatography method for determination of Lercanidipine hydrochloride in bulk and tablet dosage form

Annex 2 Formaldehyde

Certificate of Analysis

LC Determination of Deferasirox in Pharmaceutical Formulation

Application Note. Author. Abstract. Pharmaceutical QA/QC. Siji Joseph Agilent Technologies, Inc. Bangalore, India

THE CATHOLIC UNIVERSITY OF EASTERN AFRICA A. M. E. C. E. A

Certificate of Analysis

CHROMATOGRAPHY, AND MASS SPECTRAL. FRACTIONS OF Lasianthus

TERTIARY BUTYLHYDROQUINONE

CHAPTER V ANALYTICAL METHODS ESTIMATION OF DICLOFENAC. Diclofenac (gift sample from M/s Micro Labs Ltd., Pondicherry)

Modernizing the USP Monograph for Acetaminophen

Simultaneous HPLC Determination of Methocarbamol, Paracetamol and Diclofenac Sodium

Certificate of Analysis

PHYSICAL CONSTANTS: MELTING POINTS, BOILING POINTS, DENSITY

Development and Validation of Stability Indicating RP-HPLC Method for the Determination of Anagrelide HCl in Pharmaceutical Formulation

STABILITY INDICATING METHOD OF RELATED IMPURITIES IN VENLAFAXINE HYDROCHLORIDE SUSTAINED RELEASE TABLETS

Certificate of Analysis

TECHNICAL TEMEPHOS. 1. Specification. Full specification WHO/SIT/19.R4 Revised 10 December Description

Transcription:

BRIEFING Propylparaben. The European Pharmacopoeia is the coordinating pharmacopeia for the international harmonization of the compendial standards for the Propylparaben monograph, as part of the process of international harmonization of monographs and general analytical methods of the European, Japanese, and United States pharmacopeias. The following monograph, which represents the ADOPTION STAGE 6 document, is based in part on comments from the Japanese Pharmacopoeia and the United States Pharmacopeia in response to the OFFICIAL INQUIRY STAGE 4 draft prepared by the European Pharmacopoeia. Differences between the ADOPTION STAGE 6 document and the current NF monograph include replacing the TLC method in the procedure for Related Substances and the titration method in the Assay with one HPLC method for both procedures. (EXC: K. Moore.) RTS C58792 Propylparaben C 10 H 12 O 3 180.20 Benzoic acid, 4 hydroxy, propyl ester; Propyl p hydroxybenzoate [94 13 3]. DEFINITION Propylparaben contains NLT 98.0% and NMT 102.0% of C 10 H 12 O 3. IDENTIFICATION A. INFRARED ABSORPTION 197M http://www.usppf.com/pf/pub/index.html 1/5

B. MELTING RANGE OR TEMPERATURE 741 : 96 99 ASSAY Change to read: PROCEDURE Sample: 1.000 g of Propylparaben in a flask fitted with a ground glass stopper : Add 20.0 ml of 1 N sodium hydroxide VS, and heat at 70 for 1 h. Cool rapidly in an ice bath. Carry out the titration of the solutions at room temperature. Titrate the excess sodium hydroxide with 1 N sulfuric acid VS, continuing the titration until the second point of inflection (see Titrimetry 541 ). Perform a blank determination (see Titrimetry 541, Residual Titrations). Each ml of 1 N sodium hydroxide is equivalent to 166.2 mg of C 10 H 12 O 3 Acceptance criteria: 98.0% 102.0% Mobile phase, Sample solution, Standard solution B, and Chromatographic system: Proceed as described in the procedure for Related Substances. System suitability Sample: Standard solution B Suitability requirements Relative standard deviation: NMT 0.85% for 6 injections Samples: Sample solution and Standard solution B Calculate the percentage of Propylparaben in the Sample solution: Result = P (R U C S )/(R S C U ) P R U C S R S C U = labeled purity of USP Propylparaben RS expressed as a percentage = peak area of propylparaben from the Sample solution = concentration of propylparaben in Standard solution B = peak area of propylparaben from Standard solution B = concentration of Propylparaben in the Sample solution Acceptance criteria: 98.0% 102.0% 1S (NF29) IMPURITIES Inorganic Impurities http://www.usppf.com/pf/pub/index.html 2/5

RESIDUE ON IGNITION 281 : NMT 0.1%, determined on 1.0 g Change to read: Organic Impurities PROCEDURE: RELATED SUBSTANCES Sample solution: 10 mg/ml of Propylparaben in acetone Standard solution A: 50 µg/ml of Sample solution in acetone Standard solution B: Dissolve 10 mg of USP MPropylparaben RS in 1 ml of the Sample solution, and dilute with acetone to 10 ml. Chromatographic system (See Chromatography 621, Thin Layer Chromatography.) Mode: TLC Adsorbent: 0.25 mm layer of chromatographic octadecylsilanized silica gel mixture Application volume: 2 µl Developing solvent system: Methanol, glacial acetic acid, and water (70:1:30) Samples: Sample solution, Standard solution A, and Standard solution B Examine the plate under short wavelength UV light, and compare the intensities of any secondary spots observed in the chromatogram of the Sample solution with that of the principal spot in the chromatogram of Standard solution A. Acceptance criteria: The intensity of any individual secondary spot in the chromatogram of the Sample solution is not greater than that of the principal spot in the chromatogram of Standard solution A (0.5%). The test is not valid unless the chromatogram of Standard solution B shows two clearly separated principal spots. PROCEDURE: RELATED SUBSTANCES Mobile phase: Methanol and a 6.8 g/l solution of potassium dihydrogen phosphate (65:35 v/v) Sample solution: Dissolve 50.0 mg of Propylparaben in 2.5 ml of methanol, and dilute with Mobile phase to 50.0 ml. Dilute 10.0 ml of this solution with Mobile phase to 100.0 ml. Standard solution A: 5.0 µg/ml each of p hydroxybenzoic acid, USP Ethylparaben RS, and USP Propylparaben RS in Mobile phase Standard solution B: Dissolve 50.0 mg of USP Propylparaben RS in 2.5 ml of methanol, and dilute with Mobile phase to 50.0 ml. Dilute 10.0 ml of this solution with Mobile phase to 100.0 ml. Standard solution C: Dilute 1.0 ml of the Sample solution with Mobile phase to 20.0 ml. Dilute 1.0 ml of this solution with Mobile phase to 10.0 ml. Chromatographic system http://www.usppf.com/pf/pub/index.html 3/5

(See Chromatography 621, System Suitability.) Mode: LC Detector: UV 272 nm Column: 4.6 mm 15 cm; 5 µm packing L1 Flow rate: 1.3 ml/min [NOTE The run time is about 2.5 times the retention time of propylparaben.] Injection size: 10 µl System suitability Sample: Standard solution A [NOTE The retention time of propylparaben is about 4.5 minutes; the relative retention times for p hydroxybenzoic acid and ethylparaben are about 0.3 and 0.7, respectively.] Suitability requirements Resolution: NLT 3.0 between the ethylparaben and propylparaben peaks Samples: Sample solution and Standard solution C [NOTE To find the correction factor for the calculation of content, multiply the peak area of p hydroxybenzoic acid by 1.4.] [NOTE Disregard any limit that is 0.2 times the area of the principal peak in the chromatogram obtained with Standard solution C (0.1%).] Acceptance criteria p Hydroxybenzoic acid: The peak area in the Sample solution is NMT the area of the principal peak in Standard solution C (0.5%). Unspecified impurities: The peak area of each impurity in the Sample solution is NMT the area of the principal peak in Standard solution C (0.5%). Total impurities: The total peak area for all impurities in the Sample solution is NMT twice the area of the principal peak in Standard solution C (1.0%). 1S (NF29) SPECIFIC TESTS COLOR OF SOLUTION http://www.usppf.com/pf/pub/index.html 4/5

Sample solution: 100 mg/ml in alcohol Comparison solution: Mix 2.4 ml of ferric chloride CS, 1.0 ml of cobaltous chloride CS, and 0.4 ml of cupric sulfate CS with 0.3 N hydrochloric acid to make 10 ml. Dilute 5 ml of this solution with 0.3 N hydrochloric acid to make 100 ml. [ NOTE Prepare and use this solution immediately. ] Samples: Alcohol, Sample solution, and Comparison solution Make the comparison by viewing the solutions downward in matched color comparison tubes against a white surface (see Color and Achromicity 631 ). Acceptance criteria: The Sample solution is clear and not more intensely colored than alcohol or the Comparison solution. ACIDITY Sample solution: To 2 ml of Sample solution prepared in the test for Color of Solution, add 3 ml of alcohol, 5 ml of carbon dioxidefree water, and 0.1 ml of bromocresol green TS. : Titrate with 0.10 N sodium hydroxide. Acceptance criteria: NMT 0.1 ml is required to produce a blue color. ADDITIONAL REQUIREMENTS PACKAGING AND STORAGE: Preserve in well closed containers. USP REFERENCE STANDARDS 11 USP Propylparaben RS USP Ethylparaben RS Auxiliary Information Please check for your question in the FAQs before contacting USP. Topic/Question Contact Expert Committee Monograph Reference Standards USP32 NF27 Page 1329 Kevin T. Moore, Ph.D. Senior Scientific Liaison 1 301 816 8369 Lili Wang, Technical Services Scientist 1 301 816 8129 RSTech@usp.org Interim Revision Announcement: USP23 NF18 No. 7 Page 3 Pharmacopeial Forum: Volume No. 36(5) Page 1405 (EXC2010) Monographs Excipients http://www.usppf.com/pf/pub/index.html 5/5